CRL vs MOH: fair value comparison
Charles River Laboratories International, Inc. and Molina Healthcare, Inc. · Updated 2026-08-31
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, CRL currently sits closer to the top of our discount ranking. CRL carries the stronger quality grade.
| CRL | MOH | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $291.50 | $200.00 |
| 12-month range | $161.25–$232.51 | $135.82–$195.62 |
| Sector rank | #103 of 113 Healthcare | #112 of 113 Healthcare |
| Quality grade | C | F |
| Leverage | Moderate | Moderate |
| Margin trend | Contracting | Contracting |
| Revenue growth | Modest | Strong |
| RSI zone | Overbought | Neutral |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: CRL fair value analysis · MOH fair value analysis